4
Changes in Ownership
TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-20-046581
Director sold 2,860 shares at $11.90 ($34,038)
- Director acquired 7,956 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Crane Rosemary A · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-08-11 | Exercise or conversion : show line 1 in the form | +7,956 | 36,369 | D | ||
| 2020-08-11 | Sale : show line 2 in the form | −2,860 | $11.90 | $34,038 | 33,509 | D |
| Open-market sales · 2,860 sh · avg $11.90 · $34,038 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-08-11 | Exercise or conversion : show line 3 in the form Restricted Share Units | −7,956 | 0 | D |
Loading xslF345X03/doc4.xml…